Funding for this research was provided by:
AbbVie (Not applicable)
Text and Data Mining valid from 2019-12-01
Received: 11 February 2019
Accepted: 29 November 2019
First Online: 19 December 2019
Ethics approval and consent to participate
: The study was approved by the Northwestern University Institutional Review Board (STU00203656) and informed consent was obtained for all participants.
: All particpants provided consent for publication prior to participating in the interview.
: SS<sup>1</sup> received research funding from AbbVie. SJ and APF have no competing interests disclose; KW received research funding from AbbVie and is the spouse of ExternalRef removed and FACIT.Trans’ President; SS<sup>2</sup> received a grant from AbbVie outside the submitted work; AG is a full-time employee of AbbVie and may own AbbVie stock or stock options; DC serves as a consultant to AbbVie, BMS, Pfizer, and AstraZeneca outside the submitted work, is President of ExternalRef removed and FACIT.Trans, and received research funding from AbbVie, Pfizer, and Clovis.